rs199675436
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001114753.3(ENG):c.121G>T(p.Glu41*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001114753.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.121G>T | p.Glu41* | stop_gained | Exon 2 of 15 | ENST00000373203.9 | NP_001108225.1 | |
ENG | NM_000118.4 | c.121G>T | p.Glu41* | stop_gained | Exon 2 of 14 | NP_000109.1 | ||
ENG | NM_001406715.1 | c.121G>T | p.Glu41* | stop_gained | Exon 2 of 8 | NP_001393644.1 | ||
ENG | NM_001278138.2 | c.-426G>T | 5_prime_UTR_variant | Exon 2 of 15 | NP_001265067.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.121G>T | p.Glu41* | stop_gained | Exon 2 of 15 | 1 | NM_001114753.3 | ENSP00000362299.4 | ||
ENG | ENST00000344849.4 | c.121G>T | p.Glu41* | stop_gained | Exon 2 of 14 | 1 | ENSP00000341917.3 | |||
ENG | ENST00000480266.6 | c.-426G>T | 5_prime_UTR_variant | Exon 2 of 15 | 2 | ENSP00000479015.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
The p.E41* pathogenic mutation (also known as c.121G>T), located in coding exon 2 of the ENG gene, results from a G to T substitution at nucleotide position 121. This changes the amino acid from a glutamic acid to a stop codon within coding exon 2. This variant was reported in three affected individuals from a family with hereditary hemorrhagic telangiectasia (HHT) (Cymerman U et al. Hum Mutat, 2003 May;21:482-92). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.